 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | UK Coalition to Stop TB |
| Street 1: | C/O-RESULTS UK |
| Street 2: | Second Floor, 13 Maddox Street |
| City: | London |
| Province: | |
| Post Code: | W1S 2QG |
| Country: | United Kingdom of Great Britain and Northern Ireland |
| Phone: | +44 (0) 207 499 8238 |
| Email: | aparna.barua@results.org.uk |
| Web Site: | http://www.stoptbuk.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| The UK Coalition to Stop TB is an alliance of UK-based organisations and individuals who share a commitment to fight TB. Membership of the UK Coalition to Stop TB is open to organisations and individuals working to address the TB epidemic in the UK and internationally, including for example, NGOs, the private sector, media, advocates, academic institutions and professional organisations. The Coalition aims to add weight to existing efforts and provide greater influence and impact through harnessing the skills, capacity and energy of all its members. The secretariat of the Coalition is currently hosted by the charity RESULTS UK, who provide a proportion of staff time to help coordinate the members and activities of the coalition. |
|
| Total number of staff in your organization: | 1 - 5 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | Unable to disclose amount |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | United Kingdom |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The UK Coalition to Stop TB works to influence key decision and policy makers within the UK Government, through advocacy and campaigning. The Coalition monitors changes within the Department of Health that impact on TB servicing in the UK as well as working closely with TB health care professionals and former patients to monitor gaps in TB servicing, championing key interventions etc. The UK Coalition to Stop TB feeds into processes that influence Government policy accordingly. | |
Geographical Reach | |
| Which country is your headquarters located in: | United Kingdom of Great Britain and Northern Ireland |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United Kingdom of Great Britain and Northern Ireland |
Specializations | |
|
Advocacy, communication and social mobilization Funding |
Specializations in Countries | |
| Advocacy, communication and social mobilization | United Kingdom of Great Britain and Northern Ireland |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: The UK Coalition to Stop TB actively supports and advocates for the roll out of DOTS Expansions and Enhancement in communications with the UK Government. Drug-Resistant TB: DR-TB remains a key advocacy issue present in all of the UK Coalition to Stop TB Campaigns for World TB Day since 2009. The UKCSTB has consistently advocated to the UK Government to mobilise resources for investment into R&D for new and improved tools to diagnose and treat DR-TB. This has significantly contributed to the UK Government's support for TB R&D which can be seen by their Year on Year increase in spending for TB R&D (spread across drugs, vaccines and diagnostics). TB-HIV: The UKCSTB currently co-hosts a a TB-HIV Working Group with the UK Consortium on AIDS and International Development which aims to engage both TB and HIV stakeholders in the UK to influence UK Government's policy on TB-HIV and international development. This working group produces policy briefing materials to influence policy and decision makers to ensure that TB-HIV is adequately addressed in government policy and that where DFID is working on health in high burden countries, it is also working to contribute towards achieving the goals set by the Global Plan. New Diagnostics: UKCSTB has members directly involved in research for new diagnostics and actively communicates latest development to UK stakeholders and the UK Government to ensure continued support for investment into the development of new diagnostics as well as support for mechanisms like UNITAID to roll-out new tools such as GeneXpert. Currently the UK Government is in the middle of a 20 year commitment to UNITAID. New TB Drugs: UKCSTB has members directly involved in research for new drugs and actively communicates latest development to UK stakeholders and the UK Government to ensure continued support for investment into the development of new drugs. New TB Vaccines: UKCSTB works closely with key initiatives such as Aeras and SATVI to communicate clear messaging and advocacy targeting the UK Government (throughout the UKCSTB campaigns), to promote and encourage continued investment to vaccine R&D. The UKCSTB has also produced press releases/statements and media articles published in the UK media to raise public awareness of TB vaccine development breakthroughs. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | July 22, 2009 |
| Last updated: | January 10, 2013 |